The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct ...

The way the world defines obesity has been in need of an overhaul, according to some experts, and it could be coming soon ...

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

The study in Nature Medicine reveals that alongside weight loss benefits, GLP-1 medications like Ozempic and Mounjaro may ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

A parasitic worm infection, also known as a helminth infection, occurs when parasitic worms, or helminths, infect the body.

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

As evidence has mounted that new diabetes and weight loss drugs can provide a variety of health benefits, the FDA has ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Weight loss jabs, such as Wegovy, have been linked to reduced risk of dementia and seizures – but increased risk of other ...